Evidence-based dose planning aims and dose prescription in image-guided brachytherapy combined with radiochemotherapy in locally advanced cervical cancer

K Tanderup, N Nesvacil, K Kirchheiner… - Seminars in radiation …, 2020 - Elsevier
The last 2 decades have witnessed the development and broad adoption of image-guided
adaptive brachytherapy (IGABT) combined with radiochemotherapy in patients with locally …

Chronic inflammation and radiation-induced cystitis: molecular background and therapeutic perspectives

C Helissey, S Cavallero, C Brossard, M Dusaud… - Cells, 2020 - mdpi.com
Radiation cystitis is a potential complication following the therapeutic irradiation of pelvic
cancers. Its clinical management remains unclear, and few preclinical data are available on …

Radiation therapy for cervical cancer: executive summary of an ASTRO clinical practice guideline

J Chino, CM Annunziata, S Beriwal, L Bradfield… - Practical radiation …, 2020 - Elsevier
Purpose This guideline reviews the evidence and provides recommendations for the
indications and appropriate techniques of radiation therapy (RT) in the treatment of …

ESGO/ESTRO quality indicators for radiation therapy of cervical cancer

C Chargari, K Tanderup, F Planchamp, L Chiva… - Radiotherapy and …, 2023 - Elsevier
Abstract Background The European Society of Gynaecological Oncology (ESGO) has
previously defined and established a list of quality indicators for the surgical treatment of …

Ring versus ovoids and intracavitary versus intracavitary-interstitial applicators in cervical cancer brachytherapy: results from the EMBRACE I study

M Serban, C Kirisits, A de Leeuw, R Pötter… - International Journal of …, 2020 - Elsevier
Purpose The aim of this study was to investigate the influence of brachytherapy technique
and applicator type on target dose, isodose surface volumes, and organ-at-risk (OAR) dose …

Risk factors and dose-effects for bladder fistula, bleeding and cystitis after radiotherapy with imaged-guided adaptive brachytherapy for cervical cancer: An EMBRACE …

S Spampinato, LU Fokdal, R Pötter… - Radiotherapy and …, 2021 - Elsevier
Purpose To identify patient-and treatment-related risk factors for fistula, bleeding, cystitis,
pain and difficulty in voiding in locally advanced cervical cancer patients treated with radio …

Recommendations from gynaecological (GYN) GEC-ESTRO working group–ACROP: target concept for image guided adaptive brachytherapy in primary vaginal …

MP Schmid, L Fokdal, H Westerveld, C Chargari… - Radiotherapy and …, 2020 - Elsevier
Background and aim External beam radiotherapy (EBRT) combined with brachytherapy has
an essential role in the curative treatment of primary vaginal cancer. EBRT is associated with …

Importance of the ICRU bladder point dose on incidence and persistence of urinary frequency and incontinence in locally advanced cervical cancer: An EMBRACE …

S Spampinato, LU Fokdal, R Pötter… - Radiotherapy and …, 2021 - Elsevier
Purpose To identify patient-and treatment-related risk factors and dose-effects for urinary
frequency and incontinence in locally advanced cervical cancer (LACC) treated with radio …

[HTML][HTML] Predictive factors for toxicity after primary chemoradiation for locally advanced cervical cancer: a systematic review

A Corbeau, WD Heemsbergen, SC Kuipers… - International Journal of …, 2024 - Elsevier
Purpose Women with locally advanced cervical cancer (LACC) undergoing primary platinum-
based chemoradiotherapy and brachytherapy often experience toxicities. Normal-tissue …

Prevention and management of radiotherapy-related toxicities in gynecological malignancies. Position paper on behalf of AIRO (Italian Association of Radiotherapy …

E Perrucci, G Macchia, A Cerrotta, AD Andrulli… - La radiologia …, 2024 - Springer
Multi-modal therapies for gynecological cancers management may determine a wide range
of side effects which depend on therapy-related factors and patient characteristics and …